CAMP
CAMP4 Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$4.41
−1.78%Leverage
- Debt / equity
- -3.42x
- Net debt / equity
- 122.30x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.03x
- Net debt / EBITDA
- 1.16x
Liquidity & coverage
- Current ratio
- 4.70x
- Quick ratio
- 4.70x
- Cash ratio
- 4.55x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $70.9M
Cash & dividend
- FCF / debt
- -12.11x
- Cash flow / debt
- -12.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026